Guidelines on the Implementation of New Rules and ......Republic of the Philippines Department of...
Transcript of Guidelines on the Implementation of New Rules and ......Republic of the Philippines Department of...
Republic of the Philippines Department of Health
Food and Drug Administration
Guidelines on the Implementation of New
Rules and Regulations on the Licensing of
Drug Distributor-Importer, Exporter, and
Wholesaler-Establishments following
Administrative Order No. 2014-00xx, dated xx
Center for Drug Regulation and Research Media Room, 1st Floor, Main Building
Civic Drive, Filinvest Corporate City, Alabang, Muntinlupa City
17 September 2014
1
Presentation Outline
A. Objectives of Meeting
B. Draft Regulation
C. Discussion
Center for Drug Regulation and Research 2
Regulation Outline
I. Rationale
II. LTO Applications
III.Exemption in Providing Another Pharmacist for Additional Licensed Activity
IV.Responsiblities of Implementing Offices
Center for Drug Regulation and Research 3
Regulation Outline
V. Transitory Provisions
VI. Repealing/Separability Clause
VII. Effectivity
VIII.Annex A: Requirements
IX. Annex B: Variations
Center for Drug Regulation and Research 4
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 5
A. OBJECTIVES OF THE MEETING
Objectives of the Meeting
Discuss the draft regulation
Gather inputs/suggestions from stakeholders
Test run the proposed forms for application
Center for Drug Regulation and Research 6
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 7
B. DRAFT REGULATION
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 8
RATIONALE
Distributor Regulation
Rationale
requirements for the applications for initial and renewal issuance of License to Operate (LTO), variations, as well as other guidelines relevant to these establishments
Center for Drug Regulation and Research 9
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 10
LTO APPLICATION
Distributor Regulation
A. Documentary Requirements
(1) Application Form
Completely filled-up
signed by the authorized personnel
duly notarized
Center for Drug Regulation and Research 11
A. Documentary Requirements
(2) Proof of Business Name Registration
For single proprietorship - Certificate of Business Registration issued by DTI
For corporation, partnership and other juridical person - Certificate of Registration issued by SEC and Articles of Incorporation
Center for Drug Regulation and Research 12
A. Documentary Requirements
(2) Proof of Business Name Registration
For cooperative - Certificate of Registration issued by the Cooperative Development Authority and the approved by-laws
For government-owned or controlled corporation - the law highlighting the provision creating such establishment
Center for Drug Regulation and Research 13
A. Documentary Requirements
(2) Proof of Business Name Registration
Must specify exact and complete address, where applicable:
Center for Drug Regulation and Research 14
• unit number • Floor • Building • Lot • Block
• street • Phase • Barangay • city/ municipality • province
A. Documentary Requirements
(3) Credentials of pharmacist and other qualified personnel
For pharmacist
• Valid PRC ID
• Certificate of Attendance to Licensing Seminar
Center for Drug Regulation and Research 15
A. Documentary Requirements
(3) Credentials of pharmacist and other qualified personnel
For other qualified personnel
• CV
• Training records to prove qualification
Center for Drug Regulation and Research 16
A. Documentary Requirements
(4) Risk Management Plan
Details on:
• identify, characterize, prevent or minimize risk
• PV activities and interventions to manage risks
Center for Drug Regulation and Research 17
A. Documentary Requirements
(5) Location Plan
• Sketch of the location
• “how to get there”
• Directions with landmarks
• GPS Coordinates
Center for Drug Regulation and Research 18
A. Documentary Requirements
(6) Proof of Payment
• OR or payment slip
Center for Drug Regulation and Research 19
A. Documentary Requirements
(7) Self-assessment Toolkit
Center for Drug Regulation and Research 20
B. Evaluation and Compliance to GDP and GSP
(1) Desktop Evaluation
• Initially reviewed by regional offices to determine compliance with Admin and tech reqts
Center for Drug Regulation and Research 21
B. Evaluation and Compliance to GDP and GSP
(2) Inspection
In addition to the submitted application, the following documents will be verified during inspection:
• QMS
• Quality manual and SOPs
• Distributorship agreements
• Reference materials
Center for Drug Regulation and Research 22
B. Evaluation and Compliance to GDP and GSP
(2) Inspection
a)Pre-opening inspection
b) Post-licensing inspection
• Routinely done
• maV may require
• Subject to regulatory action
Center for Drug Regulation and Research 23
B. Evaluation and Compliance to GDP and GSP
(2) Inspection
Preliminary report shall be issued to the establishment after inspection
Carrying temperature sensitive products – compliance with cold-chain mgmt
Center for Drug Regulation and Research 24
C. Application for Variation
1. Major Variation
a. Change of ownership
b. Transfer of location
Center for Drug Regulation and Research 25
C. Application for Variation
2. Minor Variation-Prior Approval
a. Change of business name
b. Change of activity
c. Zonal Change
Center for Drug Regulation and Research 26
C. Application for Variation
3. Minor Variation-Notification
a. Change of Pharmacist or other Qualified Personnel
b. Deletion of Activity
Center for Drug Regulation and Research 27
C. Application for Variation
Other changes – notified to FDA
Other variations may be added
Transfer of location – initial fee
Other variations – existing fee
Center for Drug Regulation and Research 28
D. Accessibility Forms – available at the FDA website
Center for Drug Regulation and Research 29
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 30
EXEMPTION IN PROVIDING ANOTHER PHARMACIST FOR
ADDITIONAL LICENSED ACTIVITY
Distributor Regulation
Exemption Exemption for Drug Distributor pharmacist to handle retailing activity provided the ff conditions are met
1. Activities belong only to one establishment (single business entity with same name registration and ownership)
Center for Drug Regulation and Research 31
Exemption Exemption for Drug Distributor pharmacist to handle retailing activity provided the ff conditions are met
2. Activities are confined only in one office/warehouse within the same premises
Center for Drug Regulation and Research 32
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 33
RESPONSIBILITIES OF IMPLEMENTING OFFICES
Distributor Regulation
FDA and Regional offices
May call on the assistance of any department office and/or government agency for the effective implementation of its rules and regulations
Center for Drug Regulation and Research 34
LGUs Enjoined in monitoring licensed
establishments
Report to FDA any violative establishments
Center for Drug Regulation and Research 35
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 36
TRANSITORY PROVISIONS
Distributor Regulation
Transitory Provision Submitted upon renewal for existing establishments
RMP
GPS Coordinates
Center for Drug Regulation and Research 37
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 38
REPEALING/ SEPARABILITY CLAUSE
Distributor Regulation
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 39
EFFECTIVITY
Distributor Regulation
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 40
ANNEX A
Distributor Regulation
Initial LTO Application 1. Application Form
2. Proof of Business Name Registration
3. Credentials of Pharmacist and other Qualified Personnel
4. Risk Management Plan
5. Location Plan
6. Proof of Payment
7. Self-Assessment Toolkit
Center for Drug Regulation and Research 41
Renewal LTO Application
1. Application Form
2. Copy of Certifications issued as a result of LTO Variation
3. Proof of Payment
4. Self-Assessment Toolkit
Center for Drug Regulation and Research 42
Reissuance of Lost or Destroyed LTO
1. Letter of Request
2. Affidavit of Loss or Destruction
3. Proof of Payment
Center for Drug Regulation and Research 43
Voluntary Cancellation 1. Letter of Request
2. Original LTO
Center for Drug Regulation and Research 44
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 45
ANNEX B
Distributor Regulation
Change of Ownership
Center for Drug Regulation and Research 46
C change of ownership of the drug establishment
D
1. Letter of Request for Change
2. Application Form
3. Proof of business name registration reflecting the
new of owner
4. Deed of sale or transfer of rights of ownership
5. Proof of payment
6. Self-Assessment Toolkit
Transfer of Location
Center for Drug Regulation and Research 47
C 1. Physical transfer of the drug establishment
2. Other variations (change of personnel, business
name) may also be included as long as the variation
is noted in the letter of request and the unique
requirements from the additional changes are
included. The fees remain the same as initial fee,
regardless of the additional variation.
Transfer of Location
Center for Drug Regulation and Research 48
D 1. Letter of Request for Change
2. Application Form
3. Proof of business name registration reflecting the
new address
4. New Location Plan
5. Proof of payment
6. Self-Assessment Toolkit
Change of Business Name
Center for Drug Regulation and Research 49
C 1. Change only in the business name
2. No transfer of location or change of ownership.
D
1. Letter of Request for Change
2. Application Form
3. Proof of business name registration reflecting the
new name of the business/drug establishment
4. Proof of payment
5. Self-Assessment Toolkit
Change of Activity
Center for Drug Regulation and Research 50
C 1. additional activity engaged by the distributor (e.g.
LTO as Distributor-Importer with additional
activity as Exporter)
2. change from the initially licensed activity (e.g. LTO
as Distributor-Importer to Distributor-Exporter)
D
1. Letter of Request for Change
2. Application Form
3. Contract Agreements to prove activity
4. Proof of payment
5. Self-Assessment Toolkit
Zonal Change
Center for Drug Regulation and Research 51
C change of the name/number of the street/building
without physical transfer of the establishment.
D
1. Letter of Request for Change
2. Application Form
3. Document issued by the local municipality as proof of
zonal change
4. Proof of payment
5. Self-Assessment Toolkit
Change of Pharmacist or Other Qualified Personnel
Center for Drug Regulation and Research 52
C 1. There is a change of the identified pharmacist
and/or other qualified personnel
2. For multiple pharmacists employed, the identified
responsible pharmacist that will be
replaced/changed shall be required to apply for
variation; the same goes for the other qualified
personnel
Change of Pharmacist or Other Qualified Personnel
Center for Drug Regulation and Research 53
D 1. Letter of Request for Change
2. Application Form
3. Credentials of the pharmacist and/or other
qualified personnel
4. Proof of payment
5. Self-Assessment Toolkit
Deletion of Activity
Center for Drug Regulation and Research 54
C deletion of any approved/added distributor activity
D
1. Letter of Request for Change
2. Application Form
3. Termination of contract or conformance letter
4. Proof of payment
5. Self-Assessment Toolkit
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 55
C. DISCUSSION
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 56
Situation 1: (1 Variation)
DIW Trade, Inc. is a license holder of drug distributor/wholesaler located at 415 Brgy., San Antonio, Doña Soledad, Parañaque City. The said company invested on additional imported pharmaceutical products supplied by a foreign distributor.
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 57
Situation 2: (1 Variation)
ABC Company with an existing and valid LTO (CDRR-NCR-DW-123) located at 56 Chino Roces Ave., Makati City wishes to transfer their ownership rights to FDS Pharma Distributor due to management decision.
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 58
Situation 3: (2 Variations)
Biolab Research Inc. is a holder of an LTO as Drug Importer located at 1234 –B Wagas St. Value Road, Pasay City. Due to financial crisis, the management decided to move into a less expensive space to maximize the expenses. During this transition, their pharmacist unexpectedly files resignation because of personal reason.
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 59
Situation 4: (1 Variation)
PRIME Corporation was issued an initial LTO as Drug Distributor – Exporter on 30 April 2014 with an opening fee of P5050.00. During the validity of its LTO, an unavoidable circumstance mandated by municipality to change its address from 25 Magiliw St. Brgy. Mayapa, Zone 12, Calamba Laguna to 25 Magiliw St. Brgy. Mayapa, Zone 10, Calamba, Laguna.
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 60
Situation 5: (2 Variations)
J&M Distributor, an existing Drug Distributor-Wholesaler/Importer with valid LTO located at Taguig City wants to terminate their contract with their foreign suppliers to focus on wholesaling. Likewise, the management decided to change its business name to One World Distributors.
Republic of the Philippines Department of Health
Food and Drug Administration
Center for Drug Regulation and Research 61